OraSure Technologies to Present at Canaccord|Genuity's 33rd Annual Growth Conference
06 August 2013 - 8:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that
Douglas A. Michels, President and CEO, will speak to the investment
community at Canaccord|Genuity's 33rd Annual Growth Conference in
Boston, MA. The conference will be simultaneously webcast over the
Internet.
Mr. Michels is scheduled to speak August 14, 2013, at
approximately 10:30 am Eastern Time (7:30 am Pacific Time).
Interested investors can access the live webcast of the
presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link. A replay
of the webcast will be available on OraSure Technologies' web site
for seven days. Alternatively, you can access the live
webcast of the presentation via the following link
http://wsw.com/webcast/canaccord10/OSUR.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. In July
2012, the Company received approval from the U.S. Food and Drug
Administration for the Company's OraQuick® In-Home HIV Test for
sale directly to consumers in the over-the-counter (OTC) market -
making it the first and only rapid OTC HIV test approved in the
U.S. In addition, the Company is a leading provider of oral fluid
sample collection, stabilization and preparation products for
molecular diagnostic applications. OraSure's portfolio of products
is sold globally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. The Company's products enable healthcare
providers to deliver critical information to patients, empowering
them to make decisions to improve and protect their health.
For more information on the Company, please go to
www.orasure.com.
CONTACT: Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024